Evidence map›Paper›PMID 39222475›Full record

ReviewMicrocirculation (New York, N.Y. : 1994)2024

Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes.

Kareem El-Ghazawi, Ukpong B Eyo, Shayn M Peirce

Abstract readReview
In one paragraph

Review in Microcirculation (New York, N.Y. : 1994), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kareem El-GhazawiDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
Ukpong B EyoDepartment of Neuroscience, University of Virginia Center for Brain Immunology and Glia School of Medicine, Charlottesville, Virginia, USA.
Shayn M PeirceDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0001-5857-5606

Funding

Biotechnology Training ProgramT32GM136615 · NIGMS · UNIVERSITY OF VIRGINIA · PI Silvia Salinas Blemker, Kimberly A. Kelly · 2020 to 2026
$3.4M
Modeling to Design Treatments for Idiopathic Lung FibrosisR01HL155143 · NHLBI · UNIVERSITY OF VIRGINIA · PI BARKER, THOMAS HARRISON, PEIRCE-COTTLER, SHAYN · 2021 to 2024
$2.2M
Modeling to Design Treatments for Vascular Pericyte Disassociation in DiabetesR21EY028868 · NEI · UNIVERSITY OF VIRGINIA · PI PEIRCE-COTTLER, SHAYN · 2018 to 2019
$433k
NEI NIH HHS R21 EY028868NHLBI NIH HHS R01 HL155143NIGMS NIH HHS T32 GM136615
6 · The paper itself

Abstract

The brain microvasculature, which delivers oxygen and nutrients and forms a critical barrier protecting the central nervous system via capillaries, is deleteriously affected by both Alzheimer's disease (AD) and type 2 diabetes (T2D). T2D patients have an increased risk of developing AD, suggesting potentially related microvascular pathological mechanisms. Pericytes are an ideal cell type to study for functional links between AD and T2D. These specialized capillary-enwrapping cells regulate capillary density, lumen diameter, and blood flow. Pericytes also maintain endothelial tight junctions to ensure blood-brain barrier integrity, modulation of immune cell extravasation, and clearance of toxins. Changes in these phenomena have been observed in both AD and T2D, implicating "pericyte pathology" as a common feature of AD and T2D. This review examines the mechanisms of AD and T2D from the perspective of the brain microvasculature, highlighting how pericyte pathology contributes to both diseases. Our review identifies voids in understanding how AD and T2D negatively impact the brain microvasculature and suggests future studies to examine the intersections of these diseases.

Indexed as

Alzheimer DiseaseBlood-Brain BarrierBrainDiabetes Mellitus, Type 2MicrovesselsPericytesAnimalsHumansAlzheimer's diseaseblood–brain barriermicrocirculationpericytetype 2 diabetes

Identifiers

PMID39222475
PMCPMC11471384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.